Hansa Biopharma at BIO-Europe 2026

Nov 9–11, 2026 Cologne, Germany ~5.8k attendees Website

Hansa Biopharma at BIO-Europe 2026 in Cologne: 1 session (1 panel discussion).

OrganizationBIO-Europe 2026 Attendance
Hansa Biopharma
Lund, Sweden
hansabiopharma.com
Biotech
Swedish biopharmaceutical company developing enzyme-based immunomodulatory treatments; its imlifidase is approved in Europe for kidney transplant desensitisation.
Panel
Tue Nov 10
14:00–14:45
Immunology under the microscope: New frontiers
What is new in drugs for autoimmune and inflammatory diseases: emerging targets, recent trial results, and where companies are investing and partnering.
with MRM Health, Merck KGaA, Claris Ventures

Explore the full BIO-Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Cologne. Leave your work email and we’ll be in touch.

Privacy

Download the full BIO-Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Hansa Biopharma

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by BIO-Europe or its organizers. Submit a correction